Insights
Factor This: Harnessing Lab-Testing Insights to Support Targeted Oncology Therapies in the Market
The second blog in our 'Factor This' series featuring Q&A with Prognos subject matter experts.
Factor This: Alerts Supercharge Your Marketing & Sales Execution
The first blog in our 'Factor This' series featuring Q&A with Prognos subject matter experts.
14,000 People Per Month: Why We Need to Work Together to Slow Blood Cancer in its Tracks
September marks Blood Cancer Awareness month. Some 14,000 people in the United States are diagnosed each month, accounting for 10%...
In the Race To Defeat Lung Cancer, Every Day Counts
Awareness, prevention, and screening. Those are the objectives of World Lung Cancer Day, celebrated each August, and the shared goals of...
Lab Results Uncover Insights for Marketers
Read an interesting article by Jason Bhan, M.D., Chief Medical Officer of Prognos, here on on PM360.
In the Fight Against Prostate Cancer, Every Month Is Men’s Health Month
Awareness. Prevention. Education. Family. Those are the themes of Men’s Health Month, celebrated every June in the U.S. with screenings,...
Deterministic or predictive profiles? How to optimize your HCP promotional activities across channels
We’re excited to share part three of our blog series about one of the most promising methodologies for life science...
What to Consider if Your Drug is a Targeted Therapy for a New Biomarker
A Follow Up to “Biomarker Testing in Non-Small Cell Lung Cancer“ By Melissa Leonhauser, General Manager, Alert & Targeting Portfolio...
Available Omnichannel HCP Data Sources
Clinical Diagnostic Data for Omnichannel HCP Promotion Marketing: Part Two We’re excited to share part two of our blog series...
Biomarker Testing in Non-Small Cell Lung Cancer
By Bill Bowman, Clinical Solutions Architect The trend toward precision medicine in oncology is epitomized by the management of patients...